Top compounds associated with response to MOGS


Feature Type Standardized
Nominal ANOVA
mRNA Gemcitabine GDSC1000 pan-cancer AAC 0.12 0.0008
mRNA Obatoclax Mesylate GDSC1000 pan-cancer AAC 0.11 0.0008
mRNA ABT-737 CTRPv2 pan-cancer AAC -0.12 0.001
mRNA NG-25 GDSC1000 pan-cancer AAC -0.092 0.002
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.096 0.002
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.002
mRNA AUY922 GDSC1000 pan-cancer AAC 0.1 0.002
mRNA Irinotecan gCSI pan-cancer AAC -0.16 0.002
mRNA JNK-9L GDSC1000 pan-cancer AAC 0.1 0.002
mRNA KIN001-102 GDSC1000 pan-cancer AAC -0.088 0.003
Download CSV